Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 151-159

  Cole, Laurence A ^a,c   Butler, Stephen A ^a   Khanlian, Sarah A ^a   Giddings, Almareena ^a   Muller, Carolyn Y ^a   Seckl, Michael J ^b   Kohorn, Ernest I ^c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c YALE UNIVERSITY   (United States)

Author keywords

Choriocarcinoma; Gestational trophoblastic disease; hCG; hCG H; Human chorionic gonadotropin; Hyperglycosylated hCG; Invasive trophoblast antigen

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; HYPERGLYCOSYLATED CHORIONIC GONADOTROPIN; UNCLASSIFIED DRUG;

ARTICLE; CHORIOCARCINOMA; CONSULTATION; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PREGNANCY DISORDER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TROPHOBLASTIC DISEASE; TROPHOBLASTIC TUMOR;

CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; PREGNANCY; TUMOR MARKERS, BIOLOGICAL;

EID: 33745894019     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.12.045     Document Type: Article

References (17)

1. Elliott M., Kardana A., Lustbader J.W., and Cole L.A. Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7 (1997) 15-32
2. Cole L.A., Shahabi S., Butler S.A., Mitchell H., Newlands E.S., Behrman H.R., et al. Utility of commonly used commercial hCG immunoassays in the diagnosis and management of trophoblastic diseases. Clin. Chem. 47 (2001) 308-315
3. Khanlian S.A., Smith H.O., and Cole L.A. Persistent low levels of hCG: a pre-malignant gestational trophoblastic disease. Am. J. Obstet. Gynecol. 188 (2003) 1254-1259
4. Cole L.A., and Khanlian S.A. Inappropriate management of women with persistent low hCG results. J. Reprod. Med. 49 (2004) 423-432
5. Hancock B.W., and Tidy J.A. Clinical management of persistent low level hCG elevation. Trophobl. Dis. Update 4 (2003) 5-6
6. Kohorn E.I. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol. Oncol. 85 (2002) 315-320
7. Cole L.A., and Sutton J.M. hCG Tests in the management of gestational trophoblastic diseases. Clin. Obstet. Gynecol. 46 (2003) 533-554
8. Cole L.A., Shahabi S., Oz U.A., BahadoSingh R.O., and Mahoney M.J. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin. Chem. 45 (1999) 2109-2119
9. Kovaleskaya G., Genbacev O., Fisher S.J., Caceres E., and O'Connor J.F. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source or choriocarcinoma-like hCG. Mol. Cell. Endocrinol. 194 (2002) 147-155
10. Cole L.A., Dai D., Leslie K.K., Butler S.A., and Kohorn E.I. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol. Oncol. 102 (2006) 144-149
11. Cole L.A., Khanlian S.A., Sutton J.M., Davies S., and Stephens N.D. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin. Biochem. 36 (2003) 647-655
12. Cole LA. O-Glycosylation of proteins in the normal and neoplastic trophoblast. Trophobl. Res. 2 (1987) 139-148
13. Lei Z.M., Taylor D.D., GercelTaylor C., and Rao C.V. Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells. Trophobl. Res. 13 (1999) 147-159
14. Cole L.A., Khanlian S.A., Giddings A., Kohorn E.I., and Berkowitz R.S. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin free β-subunit, a reliable marker for placental site trophoblastic tumors. Gynecol. Oncol. 102 (2006) 159-163
15. Cole L.A., Sutton J.M., Higgins T.N., and Cembrowski G.S. Between-method variation in hCG test results. Clin. Chem. 50 (2004) 874-882
16. Cole L.A., and Sutton J.M. Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases. J. Reprod. Med. 49 (2004) 545-553
17. Paradinas F.J., Sbire N.J., and Pathology H.C.R. In: Hancock B.W., Newlands E.S., Berkowitz R.S., and Cole L.A. (Eds). Gestational trophoblastic disease (2003), Sheffield University, Sheffield (UK) 77-129